한빛사논문 | BRIC

유창훈 님의 논문 목록

울산대학교 의과대학 서울아산병원 종양내과

CV File 203 kb

- 유창훈(울산대학교 의과대학 서울아산병원 종양내과)
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
- J. Hepatol., November 10, 2024 | DOI: 10.1016/j.jhep.2024.10.04
- 2024-11
- 의약학
- 한빛사논문
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
- Liver Cancer, August 20 2024 | https://doi.org/10.1159/000540969
- 2024-08
- 의약학
- 한빛사논문
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in biliary tract cancer
- Clin. Cancer Res., Aug 16 2024, | https://doi.org/10.1158/1078-0432.CCR-24-1265
- 2024-08
- 의약학
- 한빛사논문
- 유창훈(울산대학교 의과대학 서울아산병원 종양내과)
Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma
- Liver Cancer, Apr 2024, 13 (2) | https://doi.org/10.1159/000531458
- 2024-04
- 의약학
- 한빛사논문
- 유창훈(울산대학교 의과대학 서울아산병원 종양내과)
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
- J. Hepatol., Available online 1 April 2024 | https://doi.org/10.1016/j.jhep.2024.03.033
- 2024-04
- 의약학
- 한빛사논문
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
- Nat. Med., Feb 19 2024, | https://doi.org/10.1038/s41591-024-02824-y
- 2024-02
- 의약학
- 한빛사논문
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.
- Hepatology, May 01 2023, 77 (5) | https://doi.org/10.1097/HEP.0000000000000046
- 2023-05
- 의약학
- 한빛사논문
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial.
- JAMA Oncol., May 01 2023, 9 (5) | https://doi.org/10.1001/jamaoncol.2023.0016
- 2023-05
- 의약학
- 한빛사논문
- 유창훈(울산대학교 의과대학 서울아산병원 종양내과)
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
- Hepatology, Sep 01 2023, 78 (3) | https://doi.org/10.1097/HEP.0000000000000365
- 2023-09
- 의약학
- 한빛사논문
- 유창훈(울산대학교 의과대학)
  Interview
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
- Lancet Oncol., Available online 14 October 2021 | https://doi.org/10.1016/S1470-2045(21)00486-1
- 2021-10
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기